SE7701796L - Forfarande for framstellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan - Google Patents

Forfarande for framstellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan

Info

Publication number
SE7701796L
SE7701796L SE7701796A SE7701796A SE7701796L SE 7701796 L SE7701796 L SE 7701796L SE 7701796 A SE7701796 A SE 7701796A SE 7701796 A SE7701796 A SE 7701796A SE 7701796 L SE7701796 L SE 7701796L
Authority
SE
Sweden
Prior art keywords
therapeutic
procedure
special
preparation
analgetic effect
Prior art date
Application number
SE7701796A
Other languages
English (en)
Other versions
SE428378B (sv
Inventor
N R
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7701796L publication Critical patent/SE7701796L/sv
Publication of SE428378B publication Critical patent/SE428378B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7701796A 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat SE428378B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
SE7701796L true SE7701796L (sv) 1977-02-17
SE428378B SE428378B (sv) 1983-06-27

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer

Country Status (27)

Country Link
JP (2) JPS5734835B2 (sv)
AR (3) AR206306A1 (sv)
AT (2) AT330773B (sv)
BE (1) BE808340A (sv)
BG (4) BG22386A3 (sv)
CA (2) CA1014560A (sv)
CH (4) CH619219A5 (sv)
CS (3) CS222209B2 (sv)
CY (1) CY1017A (sv)
DD (3) DD110864A5 (sv)
DE (1) DE2361340C2 (sv)
DK (1) DK134717B (sv)
ES (4) ES421291A1 (sv)
FR (1) FR2209578B1 (sv)
GB (2) GB1455997A (sv)
HK (1) HK60479A (sv)
HU (2) HU168620B (sv)
IE (1) IE40226B1 (sv)
IL (1) IL43773A (sv)
KE (1) KE2976A (sv)
MY (1) MY8000064A (sv)
NL (1) NL7316839A (sv)
PH (2) PH15197A (sv)
SE (3) SE403377B (sv)
SU (4) SU587861A3 (sv)
YU (3) YU35447B (sv)
ZA (1) ZA739207B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013169531A1 (en) * 2012-05-09 2013-11-14 Boehringer Ingelheim International Gmbh Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
CS193480B2 (en) 1979-10-31
SE428378B (sv) 1983-06-27
CH605903A5 (sv) 1978-10-13
SU578001A3 (ru) 1977-10-25
AR206306A1 (es) 1976-07-15
SE403377B (sv) 1978-08-14
BG22386A3 (sv) 1977-02-20
SU663305A3 (ru) 1979-05-15
AT332396B (de) 1976-09-27
ATA1026173A (de) 1976-01-15
DD115653A5 (sv) 1975-10-12
IL43773A (en) 1979-05-31
SE7701795L (sv) 1977-02-17
FR2209578A1 (sv) 1974-07-05
ES421291A1 (es) 1976-07-01
JPS4987680A (sv) 1974-08-22
YU318473A (en) 1980-09-25
DK134717C (sv) 1977-05-31
JPS5742633B2 (sv) 1982-09-09
YU36020B (en) 1981-11-13
GB1455998A (en) 1976-11-17
DE2361340A1 (de) 1974-06-12
CH619219A5 (en) 1980-09-15
CY1017A (en) 1979-11-23
BE808340A (fr) 1974-06-07
SU587861A3 (ru) 1978-01-05
DK134717B (da) 1977-01-03
FR2209578B1 (sv) 1977-09-02
ES421290A1 (es) 1976-07-01
AT330773B (de) 1976-07-26
YU35447B (en) 1981-02-28
CA1024150A (en) 1978-01-10
GB1455997A (en) 1976-11-17
JPS4987681A (sv) 1974-08-22
SE417196B (sv) 1981-03-02
CH614439A5 (en) 1979-11-30
AR212012A1 (es) 1978-04-28
HU168620B (sv) 1976-06-28
ES444911A1 (es) 1977-09-01
YU36171B (en) 1982-02-25
AR212416A1 (es) 1978-07-14
KE2976A (en) 1979-07-20
ZA739207B (en) 1975-07-30
ATA1026073A (de) 1975-10-15
NL7316839A (sv) 1974-06-11
ES444716A1 (es) 1977-05-16
BG21409A3 (sv) 1976-05-20
CS222209B2 (en) 1983-05-27
CA1014560A (en) 1977-07-26
BG21223A3 (sv) 1976-03-20
PH14923A (en) 1982-01-29
DD109625A5 (sv) 1974-11-12
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
IE40226L (en) 1974-06-08
DE2361340C2 (de) 1983-11-24
IL43773A0 (en) 1974-03-14
BG26205A4 (sv) 1979-02-15
JPS5734835B2 (sv) 1982-07-26
YU109380A (en) 1981-04-30
MY8000064A (en) 1980-12-31
IE40226B1 (en) 1979-04-11
HK60479A (en) 1979-08-31
AU6321773A (en) 1975-06-05
CS222208B2 (en) 1983-05-27
HU168763B (sv) 1976-07-28
DD110864A5 (sv) 1975-01-12
YU318573A (en) 1981-06-30
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
SE387122B (sv) Forfarande for framstellning av pyrano(3,4-b)indol- eller tiopyrano(3,4-b)indolderivat med terapeutisk verkan
SE415761B (sv) Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE407575B (sv) Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan
SE413244B (sv) Forfarandefor framstellning av bensopyraner med analgetisk verkan
FI54481C (fi) Foerfarande foer framstaellning av 5,8-dihydro-2-(1-piperazinyl)-5-oxo(2,3-d) pyrimidin-6-karboxylsyror med terapeutisk verkan
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
AR197485A1 (es) Procedimiento para la preparacion de nuevos derivados de la isoindolinona
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE400767B (sv) Forfarande for framstellning av arylpiperazin-derivat av adenin
SE7701796L (sv) Forfarande for framstellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
NO144069C (no) Difluorbutyrofenonderivater som er anvendelige for fremstilling av terapeutisk aktive butyrofenonderivater
SE402914B (sv) Forfarande for framstellning av 6-metyl-2h-pyran-2,4 (3h)-dion-derivat med hypotensiv verkan
SE394430B (sv) Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat
SE385897B (sv) Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan